Mendel

Mendel Launches Hypercube, an AI-Copilot for Real World Data Applications

Retrieved on: 
星期一, 十月 9, 2023
Oncology, Health, Technology, Health Technology, Clinical Trials, Artificial Intelligence, Oak, University of Pennsylvania, Language, Multimedia, RWD, News, SQL, Organization, LLM, Software as a service, University, Clinical trial, RNAi Global Initiative, Hallucination, Patient, Medical device, Mendel, Hypercube

Using Hypercube, organizations can now command the full spectrum of their data, structured and unstructured alike, to deliver blazing-fast insights and answer previously unanswerable questions.

Key Points: 
  • Using Hypercube, organizations can now command the full spectrum of their data, structured and unstructured alike, to deliver blazing-fast insights and answer previously unanswerable questions.
  • View the full release here: https://www.businesswire.com/news/home/20231009364497/en/
    The current approach of leveraging AI in health data relies solely on machine learning techniques like neural networks and large language models (LLMs).
  • However, this approach is inadequate for clinical applications because of its inability to discern the nuances of clinical language and susceptibility to hallucinations (unpredictable errors or inaccuracies).
  • “After six years of R&D, Hypercube is not a step forward for real-world data applications, it is a leap to RWD 2.0,” said Dr. Karim Galil, co-founder and CEO of Mendel.

Mendel Appoints Two Executive Leaders to Support Expansion in Healthcare Market

Retrieved on: 
星期二, 七月 19, 2022
Software, Research, Professional Services, Technology, Artificial Intelligence, Health Technology, Data Analytics, Clinical Trials, Science, Practice Management, Consulting, Health, CEO, Real world data, Academic health science centre, Columbia University Irving Medical Center, Real, Technology, Product management, DCM, Marketing, Organization, Medicine, McKinsey & Company, Lead, 2021 Essex County Council election, VP, EMR, Management, Pharmaceutical industry, Mendel, Genentech

Challapalli and Kalvaria bring significant experience to the Mendel team to aid the companys strategic expansion.

Key Points: 
  • Challapalli and Kalvaria bring significant experience to the Mendel team to aid the companys strategic expansion.
  • Were excited to welcome Sailu and Hylton to Mendels executive leadership team, said Karim Galil, co-founder and CEO of Mendel.
  • Sailu and Hylton hail from some of the most important and disruptive real world evidence companies in the world.
  • Challapalli has nearly two decades of experience working in healthcare consulting, academic medical centers, and healthcare technology companies.

Mendel Raises $40 Million Series B Round to Expand its Team and Grow Product Offering

Retrieved on: 
星期四, 四月 21, 2022
Resolve, CEO, Oak, SoFi, Real world data, Medicine, TikTok, DCM, Real, Twitter, Hims & Hers Health, EMR, Entrepreneurship, General partnership, SAN, LinkedIn, Growth, Technology, CT, Science and technology in Asia, Solution, Hers, AI, 2021 Essex County Council election, Silicon, Industry, Face, Medical device, Pharmaceutical industry, Mendel

The round includes participation from existing investor DCM, who led Mendel's Series A funding round in June 2021.

Key Points: 
  • The round includes participation from existing investor DCM, who led Mendel's Series A funding round in June 2021.
  • The fresh capital will enable the company to expand its team of AI and engineering teams and scale the commercial organization.
  • "The capital we have raised is a testament to the strong market fit and demand," said Karim Galil, Co-Founder and CEO of Mendel.
  • "We believe Mendel can become a mission-critical infrastructure platform for the healthcare industry," said Billy Deitch, Partner at Oak HC/FT.

Visby Medical Appoints Terri S. Bresenham and Scott Edward Mendel to Board of Directors

Retrieved on: 
星期二, 一月 4, 2022
Growth, Jack Elton Bresenham, Infection, Diagnosis, COVID-19, GE Healthcare, Media, Board, Northwestern University Master of Product Design and Development Management, FDA, PCR, Woman, Active Network, LLC, SAN, Narayana Health, Kellogg School of Management, University of Texas at Austin, Company, University of Tennessee, Health technology, Physician, Roche, Biomedical engineering, Product life-cycle theory, Hand, Multimedia, CEO, CFO, University, View, Board of directors, General Electric, Patient, Health minister, Active networking, Biomedicine, Director, Mendel, Management, Pharmaceutical industry, Indiana University, Chemistry, Visby

SAN JOSE, Calif., Jan. 4, 2022 /PRNewswire/ -- Visby Medical , a leading medical diagnostic company, today announced Terri Bresenham and Scott Mendel have been appointed to the company's Board of Directors.

Key Points: 
  • SAN JOSE, Calif., Jan. 4, 2022 /PRNewswire/ -- Visby Medical , a leading medical diagnostic company, today announced Terri Bresenham and Scott Mendel have been appointed to the company's Board of Directors.
  • Bresenham was most recently chief innovation officer at General Electric Corporation and Mendel was chief executive officer of GenMark Diagnostics.
  • Together they bring over 45 cumulative years of experience in the medical device industry to the company's board.
  • Mendel also serves on the Board of Directors of Akoya Biosciences and is on the advisory board of Specific Diagnostics.Heearned a B.S.

Kramer Levin Elevates Three to Counsel and Four to Special Counsel

Retrieved on: 
星期一, 一月 3, 2022
Legal, Professional Services, Loyola University, U.S. Securities and Exchange Commission, Culture, Loyola University Maryland, Bankruptcy, Fordham University School of Law, Investment, USC Gould School of Law, Cornell University, Bachelor of Civil Law, Bachelor, University School, Graduate diploma, Benjamin, LL.B, University College Dublin, Trustee, Silicon, Organization, Eleni, University of the Witwatersrand, University, Georgetown University, Benjamin N. Cardozo School of Law, Rabbinic Judaism, Security (finance), Seminary, Levin, LL.M, Mendel, Chapter 11, Title 11, United States Code, Financial services, Real estate, Law

Kramer Levin is pleased to announce the promotions of Darina F. Delappe, Lancelot Montmeterme and Jennifer R. Sharret to counsel and the promotions of Jennifer Raiola Danzo, Jeffrey H Taub, M. Mendel Trapedo and Eleni Zanias to special counsel.

Key Points: 
  • Kramer Levin is pleased to announce the promotions of Darina F. Delappe, Lancelot Montmeterme and Jennifer R. Sharret to counsel and the promotions of Jennifer Raiola Danzo, Jeffrey H Taub, M. Mendel Trapedo and Eleni Zanias to special counsel.
  • Co-managing partners Paul H. Schoeman and Howard T. Spilko said, We congratulate our new counsel and special counsel, applaud all they have accomplished, and look forward to their continued success.
  • She also advises clients on co-investments, seed investments, the organization of joint ventures and various compliance matters.
  • Kramer Levin provides its clients proactive, creative and pragmatic solutions that address todays most challenging legal issues.

Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors

Retrieved on: 
星期五, 六月 25, 2021
Calliostomatidae, Akoya, Mendel

MARLBOROUGH, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company, today announced the appointment of diagnostics industry leader Scott Mendel to its board of directors.

Key Points: 
  • MARLBOROUGH, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (NASDAQ: AKYA), The Spatial Biology Company, today announced the appointment of diagnostics industry leader Scott Mendel to its board of directors.
  • I am delighted to join the board of directors of Akoya, a company that has the potential to transform biomarker discovery and clinical research through the application of its spatial biology platforms, Mr. Mendel said.
  • Mr. Mendel is currently CEO of GenMark Diagnostics, a highly innovative and successful molecular diagnostics company.
  • We are excited and honored to have Scott join Akoyas Board of Directors, said Brian McKelligon, CEO, Akoya Biosciences.

Clinical AI Technology Leader Mendel Raises $18M in New Capital

Retrieved on: 
星期一, 六月 7, 2021
Data management, Health, Technology, Other Technology, Practice Management, Software, Articles, Academic disciplines, Artificial intelligence, Computational neuroscience, Cybernetics, DCM, Science and technology, Mendel, DCM, MENDEL, DCM

The oversubscribed round was led by DCM, a global venture capital firm, with participation from OliveTree, Zola Global Investors and Millennium Technology Value Partners.

Key Points: 
  • The oversubscribed round was led by DCM, a global venture capital firm, with participation from OliveTree, Zola Global Investors and Millennium Technology Value Partners.
  • The capital will help the company rapidly grow its business and sales team to keep up with the explosive demand for clinical AI technologies by healthcare organizations over the last year.
  • There is huge potential for the global healthcare industry to leverage AI, said Mendel board member and partner at DCM, Kyle Lui.
  • Mendel has created a unique and seamless solution for healthcare organizations to automatically make sense of their clinical data using AI.

Mendel Launches AI-powered Search Engine to Analyze More Than 50,000 Coronavirus Papers

Retrieved on: 
星期二, 四月 7, 2020
Data management, Practice Management, Technology, Professional services, Health, Research, Infectious diseases, Software, Internet, Science, Finance, Viruses, Articles, Animal virology, Coronavirus, Artificial intelligence, Mendel, DCM

Mendel , the leader in clinical AI technologies, announced the launch of a new search engine using proprietary AI to absorb more than 50,000 coronavirus research papers and answer questions related to COVID-19.

Key Points: 
  • Mendel , the leader in clinical AI technologies, announced the launch of a new search engine using proprietary AI to absorb more than 50,000 coronavirus research papers and answer questions related to COVID-19.
  • The search engine parses scholarly articles on coronaviruses made publicly available by the White House.
  • This is a process that takes humans numerous hours, days, or even weeks to conduct when comparing medical literature.
  • For example, the search engine is trained to be asked highly specific questions, like, What are the modes of transmission of a virus?